MedPath

A clinical trial to compare the efficacy of intravenous levetiracetam and intravenous phenytoin in control of convulsive status epileptics in children from age group one to twelve years

Phase 4
Completed
Conditions
Generalized idiopathic epilepsy and epileptic syndromes,
Registration Number
CTRI/2020/01/022641
Lead Sponsor
Dr Pooja Shankar Sawlani
Brief Summary

This study is an open labelled randomised controlled trial to compare efficacy of intravenous levetiracetam 40 mg per kg per min and intravenous phenytoin 20 mg per kg per min in management of convulsive status epileptics in children. The outcome of the study it to provide data that intravenous levetiracetam is superior to intravenous phenytoin.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
204
Inclusion Criteria

All children from age of one year to 12 years presenting in status epilepticus not controlled by initial emergent therapy with benzodiazepines as per ILAE Protocol.

Exclusion Criteria
  • 1.Status epilepticus controlled by initial emergent therapy with benzodiazepines.
  • 2.Children less than one year of age and >12 years Received loading dose of second-line anticonvulsants (Phenytoin, Phenobarbitone, Valproate, Levetiracetam) for control of current status epilepticus 3.History of Head injury.
  • 4.Convulsions due to acute metabolic / electrolyte disturbances.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intravenous levetiracetam is superior to intravenous phenytoin in control of convulsions in paediatric population24 months
Secondary Outcome Measures
NameTimeMethod
To provide data regarding decrease incident of recurrence of convulsion while using intravenous levetiracetam in comparison to intravenous phenytoin1 day

Trial Locations

Locations (1)

Paediatrics ward

🇮🇳

Aurangabad, MAHARASHTRA, India

Paediatrics ward
🇮🇳Aurangabad, MAHARASHTRA, India
Dr Pooja Shankar Sawlani
Principal investigator
7875016662
poojasaw17@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.